Key Takeaways

A new drug combo is more effective in treating advanced prostate cancer

The targeted drug niraparib added to hormone therapy slowed cancer growth and symptom progression

Signs show the combo might also improve survival

FRIDAY, Oct. 10, 2025 (HealthDay News) — A new drug combo is offering hope for men with advanced prostate cancer .

Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom advance, according to findings published Oct. 7 in the journal Nature Medicine .

The combination was even more effective among men with genetic mutations driving their prostate cancer, researchers noted.

“Although current standard treatments are very effective for the majority of patients with advanced prostate ca

See Full Page